1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PETROS PHARMACEUTICALS INC
Petros Pharmaceuticals Inc XNAS: PTPI

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Petros Pharmaceuticals Inc

The latest disclosure was made by Mitchell Arnold in Petros Pharmaceuticals Inc where a trade of 150,000 Common Stock done was reported to US exchanges on Feb. 19, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mitchell Arnold See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 150,000 150,000 - 0 Common Stock
Fady Boctor See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 450,000 499,645 - 0 Common Stock
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 300,000 308,346 - 0 Common Stock
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 1,000,000 1,011,237 - 0 Common Stock
Fady Boctor See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 49,645 49,645 - 0 Common Stock
Mitchell Arnold See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 20,000 20,000 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 40,000 40,000 - - Stock Option (Right to Buy)
Gregory Bradley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 40,000 40,000 - - Stock Option (Right to Buy)
Joshua Silverman Nathaniel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 40,000 40,000 - - Stock Option (Right to Buy)
Boctor Fady See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 54,533 54,533 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,050 8,346 - - Common Stock
Bruce Bernstein T. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,050 0 - - Restricted Stock Units
Nathaniel Joshua Silverman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,722 0 - - Restricted Stock Units
Gregory Bradley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,050 0 - - Restricted Stock Units
Nathaniel Silverman Joshua Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,722 11,237 - - Common Stock
Gregory Bradley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 6,050 8,314 - - Common Stock
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 39,000 39,000 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 39,000 39,000 - - Stock Option (Right to Buy)
Gregory Bradley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 39,000 39,000 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,264 0 - - Restricted Stock Units
Bruce T. Bernstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,264 2,296 - - Common Stock
Joshua Nathaniel Silverman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,515 0 - - Restricted Stock Units
Joshua Nathaniel Silverman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,515 4,515 - - Common Stock
Gregory Bradley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,264 2,264 - - Common Stock
Gregory Bradley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2023 2,264 0 - - Restricted Stock Units
Gregory Bradley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2022 60,505 60,505 - - Restricted Stock Units
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2022 60,505 60,505 - - Restricted Stock Units
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2022 67,227 67,227 - - Restricted Stock Units
John D. Shulman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Nov 2021 375,000 375,000 - - Warrant
John D. Shulman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.00 per share. 29 Nov 2021 500,000 5,557,771 - 3 1,500,000 Common Stock, par value $0.0001 per share
John D. Shulman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.71 per share. 18 Oct 2021 1,661,807 5,057,771 - 1.7 2,849,999 Common Stock, par value $0.0001 per share
John D. Shulman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Oct 2021 1,661,807 1,661,807 - - Warrant
Mitchell Arnold Prin. Acct. Off/Prin. Fin. Off Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 50,000 50,000 - - Stock Option (right to buy)
Andrew Gesek President, Timm Medical Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 75,000 75,000 - - Stock Option (right to buy)
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
John D. Shulman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
Gregory Bradley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 50,000 50,000 - - Stock Options (right to buy)
Fady Boctor Pres. & Chief Comm. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2021 215,669 215,669 - - Stock Options (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 24,855 24,855 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 20,000 20,000 - - Common Stock, par value $0.0001 per share
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 1,875 1,875 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 2,000 2,000 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 33,400 33,400 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 2,000 2,000 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 30,000 30,000 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 2,000 2,000 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 2,000 2,000 - - Employee Stock Option (right to buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 20,000 20,000 - - Employee Stock Option (right to buy)
Keith Lavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 975 975 - - Common Stock, par value $0.0001 per share
Andrew Gesek President, Timm Medical Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 97 97 - - Common Stock, par value $0.0001 per share
John D. Shulman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2020 3,395,964 3,395,964 - - Common Stock, par value $0.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters